“Arsenic, Disordered Glucose Homeostasis and Atherosclerosis”
Investigators will recruit 250 subjects; Group A will consist of 100 prediabetic patients with an A1c of 5.7%-6.4%. Group B will consist of 100 patients with uncontrolled T2D defined as either a) an A1c of 6.5%-7.9% without diabetes medications or b) an A1c a?Y 8.0% with or without diabetes medications. Group C will include 50 participants without T2D or known cardiovascular disease to serve as control comparisons.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol